Last reviewed · How we verify
NCT01141998
Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption
NA trial testing Calcium, Dietary in Chronic Pancreatitis in 27 participants. Completed in 1 March 2011.
1 May 2010
Quick facts
| Lead sponsor | Hvidovre University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 1 December 2009 |
| Primary completion | 1 May 2010 |
| Estimated completion | 1 March 2011 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Calcium, Dietary — full drug profile →
- Cholecalciferol (cholecalciferol) — full drug profile →
- UVB
- UV-filtered light.
- Cholecalciferol (cholecalciferol) — full drug profile →
Conditions studied
- Chronic Pancreatitis — all drugs for Chronic Pancreatitis →
- Malabsorption Syndromes — all drugs for Malabsorption Syndromes →
Sponsor
Hvidovre University Hospital
Who can join
18 and older, any sex, with Chronic Pancreatitis or Malabsorption Syndromes. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
25-hydroxyvitamin D
Time frame: Week 0, 2, 6, 10, 14, 20, 30, 40, 52
Sponsor's own description
Purpose: The overall objective of this study is to learn more about the disease chronic pancreatitis and thus contribute to better treatments. The investigators will gain this by studying the effects of vitamin D in the body immune system and bones. The investigators will also study the uptake of vitamin D through the intestine compared with the amount of vitamin D obtained through exposure to UVB rays. The investigators have set a series of questions which the investigators want to answer with this experiment: Do patients with chronic pancreatitis have reduced absorption of vitamin D from the gut? * Have the two treatment methods with vitamin D, UV radiation and tablets, the same success rate? * Does the distribution of the white blood cells change when the vitamin D level increases and does it depend on whether the patient have UVB radiation or tablet with vitamin D? * Will patients require reduced amounts of painkillers when vitamin D level increases? * Does vitamin D have influence on blood sugar and thus the risk of diabetes or worsening of this? * Could vitamin D affect the blood content of inflammation markers? * Does the patient feel better when he takes vitamin D? * Does bone strength increase when the patients receive grants of vitamin D?
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vitamin D: A Potential Star for Treating Chronic Pancreatitis.
Zheng M, Gao R. · · 2022 · cited 8× · PMID 35734414 · DOI 10.3389/fphar.2022.902639
Verify or expand the search:
- PubMed search for NCT01141998
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Pancreatitis
Currently open trials in the same condition.
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
- NCT06655051 — Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancr · NA · recruiting
- NCT06937294 — Metformin in Post Chronic Pancreatitis Diabetes Mellitus · Phase 4 · recruiting
- NCT07109180 — Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOT · NA · recruiting
- NCT06925204 — Natural Course and Therapeutic Effect of Chronic Pancreatitis · recruiting
Other Hvidovre University Hospital trials
Trials by the same sponsor.
- NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
- NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01141998 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
- Last refreshed: 22 December 2011
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01141998.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing